Nanoform Finland Plc (NANOFH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanoform Finland Plc (NANOFH) has a cash flow conversion efficiency ratio of -0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.38 Million ≈ $-3.95 Million USD) by net assets (€44.58 Million ≈ $52.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanoform Finland Plc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Nanoform Finland Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Nanoform Finland Plc carry for a breakdown of total debt and financial obligations.
Nanoform Finland Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanoform Finland Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bound and Beyond PCL
BK:BEYOND
|
0.068x |
|
Clene Inc.
NASDAQ:CLNN
|
0.274x |
|
Sempio Foods Co
KO:248170
|
0.068x |
|
Grong Sparebank
OL:GRONG
|
N/A |
|
Hyundai E P
KO:089470
|
-0.028x |
|
Flexible Solutions International Inc
NYSE MKT:FSI
|
-0.069x |
|
ProfilGruppen AB (publ)
ST:PROF-B
|
-0.017x |
|
MAG Holdings Berhad
KLSE:0095
|
-0.125x |
Annual Cash Flow Conversion Efficiency for Nanoform Finland Plc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Nanoform Finland Plc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Nanoform Finland Plc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €60.03 Million ≈ $70.18 Million |
€-18.28 Million ≈ $-21.37 Million |
-0.304x | -13.22% |
| 2023-12-31 | €66.95 Million ≈ $78.27 Million |
€-18.00 Million ≈ $-21.05 Million |
-0.269x | -16.79% |
| 2022-12-31 | €87.21 Million ≈ $101.96 Million |
€-20.08 Million ≈ $-23.48 Million |
-0.230x | -35.58% |
| 2021-12-31 | €84.49 Million ≈ $98.78 Million |
€-14.35 Million ≈ $-16.78 Million |
-0.170x | +24.86% |
| 2020-12-31 | €62.64 Million ≈ $73.23 Million |
€-14.16 Million ≈ $-16.55 Million |
-0.226x | +69.08% |
| 2019-12-31 | €7.93 Million ≈ $9.27 Million |
€-5.80 Million ≈ $-6.78 Million |
-0.731x | -144.64% |
| 2018-12-31 | €5.03 Million ≈ $5.88 Million |
€-1.50 Million ≈ $-1.76 Million |
-0.299x | -111.03% |
| 2017-12-31 | €-246.96K ≈ $-288.72K |
€-669.18K ≈ $-782.34K |
2.710x | -- |
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more